Invesco Ltd. Legend Biotech Corp Transaction History
Invesco Ltd.
- $503 Billion
- Q1 2025
A detailed history of Invesco Ltd. transactions in Legend Biotech Corp stock. As of the latest transaction made, Invesco Ltd. holds 2,936,703 shares of LEGN stock, worth $105 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,936,703
Previous 3,309,971
11.28%
Holding current value
$105 Million
Previous $108 Million
7.49%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
74.4MCall Options Held
247KPut Options Held
406K-
Westfield Capital Management CO LP Boston, MA6.92MShares$248 Million1.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.73MShares$241 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$215 Million6.23% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$205 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.75MShares$135 Million5.57% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...